compounded retatrutide Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type 2 Diabetes Trial Extreme Side Effects Followed Overdose

Retatrutides 24.2% average weight loss at 48 weeks is the highest ever recorded in obesity pharmacotherapy trials

Unlike most medications, the absorption of this tablet is highly sensitive to food and drink

Most digestive side effects tend to appear in the first few weeks of treatment, particularly while the dose is being gradually increased

Incorporating this botanical product into a balanced diet supports healthy metabolism as well as regular digestive and muscle function without risking undernutrition.* Bariatric Fusions bariatric multivitamins and supportive supplements are formulated by a team of bariatric practitioners to support nutrient absorption for those who have undergone ASMBS-endorsed procedures, including duodenal switch, SIPS, SADI-S, sleeve gastrectomy, gastric bypass surgery, lap band, and intra-gastric balloon

While originally designed for Type 2 diabetes, GLP-1 drugs are now used for obesity, PCOS, cardiovascular protection, liver disease, and even neurological disorders